Anpac Bio has partnerships with more than 140 major hospitals and clinical testing centers, and over 200 science, technology, government, nonprofit, educational, and advocacy organizations, worldwide. Among them:
RESEARCH AND CLINICAL TRIALS
Anpac Bio is working with internationally-respected medical institutions to develop R&D investigations and formal clinical trials in the United States. These trials are in addition to the ~50,000 cases that have successfully been conducted globally.
OTHER SCREENING AND DETECTION SERVICES
In addition to Anpac Bio’s proprietary CDA medical devices, the company is developing a multitude of disease screening and detection services, reagents, testing processing and services, data management, consulting services, and innovative health-related training and technology.